A Comparison of Renal vs Limb NIRS for Predicting Cardiac Surgery Associated Acute Kidney Injury
Launched by UNIVERSITY OF UTAH · Nov 22, 2024
Trial Information
Current as of July 09, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a technology called Near Infrared Spectroscopy (NIRS) to see if it can help predict a complication known as acute kidney injury (AKI) in patients undergoing heart surgery. AKI is a condition where the kidneys suddenly stop working well, and it's a concern for patients having cardiac surgery that requires a heart-lung machine (called cardiopulmonary bypass). The researchers want to find out if placing NIRS sensor stickers over the kidneys can better predict AKI compared to when these sensors are placed on the arms or legs.
To participate in this study, you would need to be an adult aged 18 or older who is scheduled for a heart surgery that involves cardiopulmonary bypass and is at risk for developing AKI. However, those with end-stage kidney disease requiring dialysis, patients needing emergency surgery, or anyone who does not want to participate will not be eligible. If you join the trial, you can expect to have a sensor placed on your skin, and your oxygen levels will be monitored during your surgery to help doctors better understand kidney health during the procedure. The study is being conducted by the University of Utah's anesthesiology department, and they are not yet recruiting participants.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • We will enroll a convenience sample of adult cardiac surgery patients undergoing procedures that require cardiopulmonary bypass (CPB) and who are at risk for AKI.
- Exclusion Criteria:
- • Exclusion criteria will include less than age 18 years old, preoperative end-stage kidney disease requiring dialysis, emergency surgery, or patient refusal.
About University Of Utah
The University of Utah is a prestigious research institution known for its commitment to advancing medical knowledge and improving patient care through innovative clinical trials. With a robust infrastructure that supports a wide range of biomedical research initiatives, the university leverages its multidisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical studies. By fostering collaboration among researchers, clinicians, and community partners, the University of Utah aims to translate scientific discoveries into effective therapies and interventions, ultimately enhancing health outcomes and contributing to the advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Salt Lake City, Utah, United States
Patients applied
Trial Officials
Natalie Silverton, MD
Principal Investigator
University of Utah
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported